The collaboration leverages LTS's background in technology transfer, scale-up, and manufacturing, providing Nualtis with resources to scale their OTF products and deliver them to patients worldwide.

LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today ...